Your browser doesn't support javascript.
loading
Effects of nirmatrelvir/ritonavir on midazolam and dabigatran pharmacokinetics in healthy participants.
Cox, Donna S; Rehman, Muhammad; Khan, Tahira; Ginman, Katherine; Salageanu, Joanne; LaBadie, Robert R; Wan, Katty; Damle, Bharat.
Affiliation
  • Cox DS; Pfizer Inc. Global Product Development, Collegeville, Pennsylvania, USA.
  • Rehman M; Pfizer Inc. Global Product Development, Andover, Massachusetts, USA.
  • Khan T; Pfizer Inc. Global Product Development, Groton, Connecticut, USA.
  • Ginman K; Pfizer Inc. Global Product Development, Groton, Connecticut, USA.
  • Salageanu J; Pfizer Inc. Global Product Development, Collegeville, Pennsylvania, USA.
  • LaBadie RR; Pfizer Inc. Global Product Development, New York, New York, USA.
  • Wan K; Pfizer Inc. Global Product Development, Collegeville, Pennsylvania, USA.
  • Damle B; Pfizer Inc. Global Product Development, New York, New York, USA.
Br J Clin Pharmacol ; 89(11): 3352-3363, 2023 11.
Article in En | MEDLINE | ID: mdl-37354048
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Midazolam / Ritonavir Limits: Adult / Humans Language: En Journal: Br J Clin Pharmacol Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Midazolam / Ritonavir Limits: Adult / Humans Language: En Journal: Br J Clin Pharmacol Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido